Maravai Competitors
| MRVI Stock | USD 3.08 0.10 3.36% |
Maravai Lifesciences vs Edwards Lifesciences Correlation
Very weak diversification
The correlation between Maravai Lifesciences Holdings and EW is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and EW in the same portfolio, assuming nothing else is changed.
Moving together with Maravai Stock
| 0.7 | A | Agilent Technologies Earnings Call This Week | PairCorr |
Moving against Maravai Stock
The Maravai Lifesciences' current Return On Tangible Assets is estimated to increase to -0.24. The Maravai Lifesciences' current Return On Capital Employed is estimated to increase to -0.27. As of now, Maravai Lifesciences' Non Currrent Assets Other are increasing as compared to previous years. The Maravai Lifesciences' current Other Assets is estimated to increase to about 973.4 M, while Other Current Assets are projected to decrease to under 15.4 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Maravai Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Maravai Lifesciences Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Maravai Lifesciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Maravai and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Maravai Lifesciences does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Maravai Stock performing well and Maravai Lifesciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Maravai Lifesciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MTD | 1.10 | (0.10) | 0.00 | (0.03) | 0.00 | 2.51 | 7.69 | |||
| ALC | 1.12 | 0.04 | 0.03 | 0.10 | 1.08 | 2.60 | 7.05 | |||
| RMD | 1.26 | (0.03) | (0.01) | 0.03 | 1.78 | 2.41 | 9.75 | |||
| HLN | 0.98 | 0.16 | 0.10 | 0.80 | 1.09 | 2.76 | 5.40 | |||
| CAH | 1.14 | 0.14 | 0.05 | (0.67) | 1.42 | 2.54 | 13.93 | |||
| BDX | 1.18 | 0.31 | 0.24 | (2.30) | 0.70 | 3.22 | 7.13 | |||
| INSM | 1.91 | (0.21) | 0.00 | 0.72 | 0.00 | 3.35 | 20.19 | |||
| EW | 1.13 | (0.17) | 0.00 | (0.16) | 0.00 | 2.36 | 6.60 |
Cross Equities Net Income Analysis
Compare Maravai Lifesciences and related stocks such as Mettler Toledo Inter, Alcon AG, and ResMed Inc Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTD | (65.9 M) | 269.5 M | 290.8 M | 306.1 M | 338.2 M | 352.8 M | 384.4 M | 376 M | 512.6 M | 561.1 M | 602.7 M | 769 M | 872.5 M | 788.8 M | 863.1 M | 869.2 M | 912.7 M |
| ALC | 931 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | (170 M) | 256 M | (227 M) | (656 M) | (531 M) | 376 M | 335 M | 974 M | 1 B | 916.2 M | 962 M |
| RMD | 800 K | 254.8 M | 307.1 M | 345.3 M | 352.9 M | 352.4 M | 342.3 M | 315.6 M | 404.6 M | 621.7 M | 474.5 M | 779.4 M | 897.6 M | 1 B | 1.4 B | 1.6 B | 1.7 B |
| HLN | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 1.1 B | 1.4 B | 1.1 B | 1 B | 1.4 B | 1.7 B | 1.2 B |
| CAH | 6 M | 1.1 B | 334 M | 1.2 B | 1.2 B | 1.4 B | 1.3 B | 256 M | 1.4 B | (3.7 B) | 611 M | (938 M) | 330 M | 852 M | 1.6 B | 1.8 B | 1.9 B |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| INSM | (7.8 M) | (59.7 M) | (41.4 M) | (56.1 M) | (79.2 M) | (118.2 M) | (176.3 M) | (192.6 M) | (324.3 M) | (254.3 M) | (294.1 M) | (434.7 M) | (481.5 M) | (749.6 M) | (913.8 M) | (822.4 M) | (781.3 M) |
| EW | 82 M | 236.7 M | 293.2 M | 391.7 M | 811.1 M | 494.9 M | 569.5 M | 622.1 M | 722.2 M | 1 B | 823.4 M | 1.5 B | 1.5 B | 1.4 B | 4.2 B | 1.1 B | 673.1 M |
Maravai Lifesciences and related stocks such as Mettler Toledo Inter, Alcon AG, and ResMed Inc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Maravai Lifesciences financial statement analysis. It represents the amount of money remaining after all of Maravai Lifesciences Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Maravai Lifesciences Competitive Analysis
The better you understand Maravai Lifesciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Maravai Lifesciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Maravai Lifesciences' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Maravai Lifesciences Competition Performance Charts
Five steps to successful analysis of Maravai Lifesciences Competition
Maravai Lifesciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Maravai Lifesciences in relation to its competition. Maravai Lifesciences' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Maravai Lifesciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Maravai Lifesciences' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Maravai Lifesciences, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Maravai Lifesciences position
In addition to having Maravai Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run EUR Crypto Assets Thematic Idea Now
EUR Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Euro. The EUR Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize EUR Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Maravai Lifesciences Correlation with its peers. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is there potential for Life Sciences Tools & Services market expansion? Will Maravai introduce new products? Factors like these will boost the valuation of Maravai Lifesciences. Expected growth trajectory for Maravai significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (0.84) | Revenue Per Share | Quarterly Revenue Growth (0.40) | Return On Assets |
Understanding Maravai Lifesciences requires distinguishing between market price and book value, where the latter reflects Maravai's accounting equity. The concept of intrinsic value - what Maravai Lifesciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Maravai Lifesciences' price substantially above or below its fundamental value.
Understanding that Maravai Lifesciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maravai Lifesciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Maravai Lifesciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.